Načítá se...
Curing Ph(+) ALL: assessing the relative contributions of chemotherapy, TKIs, and allogeneic stem cell transplant
The understanding and treatment of Philadelphia chromosome-positive (Ph(+)) acute lymphoblastic leukemia have changed rapidly in the past 10 years. The outcome is equally as good as for Ph(−) disease, and with targeted tyrosine kinase inhibitor therapies in addition to chemotherapy, the novel immuno...
Uloženo v:
| Vydáno v: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Hematology
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913432/ https://ncbi.nlm.nih.gov/pubmed/31808885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000010 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|